Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

Don’t let eczema control your child's life! Discover expert tips on managing atopic dermatitis for a happier, itch-free ...

异位性皮肤炎不仅会伤害患者的皮肤，也可能影响生活质量和日常活动。新加坡中央医院将在9月13日（星期五）举办“异位性皮肤炎——不止是皮肤表层问题”（Atopic Dermatitis – More than skin deep?）线上英语讲座。

Introduction: Eczema, also known as atopic dermatitis, is a common skin condition characterized by dry, itchy skin. While ...

The atopic dermatitis (AD) market is projected to reach $16.7 billion by 2030, according to GlobalData. New therapies like ...

Dermatologists explain how hypochlorous acid can treat redness and acne, and suggest some more products that use it.

The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 ...

Atopic dermatitis, for its part, affects roughly 16.5 million adults and 9.6 million children in the U.S. According to ...

Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...

FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic ...